SS Innovations International (SSII) Reports Record Q2 Revenue of $13.9M, Up 39.4%

LOS ANGELES, CA - August 14, 2026 (NEWMEDIAWIRE) - SS Innovations International (NASDAQ: SSII) reported record second-quarter 2026 revenue of $13.9 million, up 39.4% from $10 million a year earlier, as installations of its SSi Mantra surgical robotic system increased 30.4% to 30. Gross profit rose 20% to $7.1 million, with gross margin of 50.9%, while net loss was $2.7 million, or $0.01 per diluted share, compared with a net loss of $0.3 million a year earlier. First-half revenue increased 65.6% to $25 million, while SSi Mantra installations rose 47.4% to 56. As of June 30, SS Innovations had $13.6 million in cash and cash equivalents, no long-term debt and a cumulative installed base of 224 SSi Mantra systems across 12 countries.

The company reported 12,272 cumulative procedures using the SSi Mantra as of June 30, including 175 telesurgeries, and subsequently completed a robotic telesurgery spanning more than 13,600 miles between Colombia and India. SS Innovations expects the U.S. Food and Drug Administration to complete its review of the company’s 510(k) premarket notification for the SSi Mantra by the end of the first quarter of 2027 and said it believes it can obtain European Union CE marking certification by the end of 2026.

To view the full press release, visit https://ibn.fm/nTMso

About SS Innovations

SS Innovations International, Inc. develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII

Forward Looking Statements

Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law

View the original release on www.newmediawire.com

This contant was orignally distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is SS Innovations International (SSII) Reports Record Q2 Revenue of $13.9M, Up 39.4%.